• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光动力疗法治疗光化性角化病的联合治疗策略:循证综述

Combination-Based Strategies for the Treatment of Actinic Keratoses with Photodynamic Therapy: An Evidence-Based Review.

作者信息

Piaserico Stefano, Mazzetto Roberto, Sartor Emma, Bortoletti Carlotta

机构信息

Dermatology Unit, Department of Medicine, University of Padua, 35121 Padua, Italy.

出版信息

Pharmaceutics. 2022 Aug 18;14(8):1726. doi: 10.3390/pharmaceutics14081726.

DOI:10.3390/pharmaceutics14081726
PMID:36015352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9416092/
Abstract

Photodynamic therapy (PDT) is a highly effective and widely adopted treatment strategy for many skin diseases, particularly for multiple actinic keratoses (AKs). However, PDT is ineffective in some cases, especially if AKs occur in the acral part of the body. Several methods to improve the efficacy of PDT without significantly increasing the risks of side effects have been proposed. In this study, we reviewed the combination-based PDT treatments described in the literature for treating AKs; both post-treatment and pretreatment were considered including topical (i.e., diclofenac, imiquimod, adapalene, 5-fluorouracil, and calcitriol), systemic (i.e., acitretin, methotrexate, and polypodium leucotomos), and mechanical-physical (i.e., radiofrequency, thermomechanical fractional injury, microneedling, microdermabrasion, and laser) treatment strategies. Topical pretreatments with imiquimod, adapalene, 5-fluorouracil, and calcipotriol were more successful than PDT alone in treating AKs, while the effect of diclofenac gel was less clear. Both mechanical laser treatment with CO and Er:YAG (Erbium:Yttrium-Aluminum-Garnet) as well as systemic treatment with Polypodium leucotomos were also effective. Different approaches were relatively more effective in particular situations such as in immunosuppressed patients, AKs in the extremities, or thicker AKs. Conclusions: Several studies showed that a combination-based approach enhanced the effectiveness of PDT. However, more studies are needed to further understand the effectiveness of combination therapy in clinical practice and to investigate the role of acitretin, methotrexate, vitamin D, thermomechanical fractional injury, and microdermabrasion in humans.

摘要

光动力疗法(PDT)是一种针对多种皮肤病,尤其是多发性光化性角化病(AK)的高效且广泛应用的治疗策略。然而,PDT在某些情况下无效,特别是当AK发生在身体的肢端部位时。已经提出了几种在不显著增加副作用风险的情况下提高PDT疗效的方法。在本研究中,我们回顾了文献中描述的用于治疗AK的基于联合治疗的PDT;考虑了治疗后和预处理,包括局部(即双氯芬酸、咪喹莫特、阿达帕林、5-氟尿嘧啶和骨化三醇)、全身(即阿维A、甲氨蝶呤和白藓)以及机械物理(即射频、热机械微损伤、微针、微晶磨皮和激光)治疗策略。用咪喹莫特、阿达帕林、5-氟尿嘧啶和骨化三醇进行局部预处理在治疗AK方面比单独使用PDT更成功,而双氯芬酸凝胶的效果不太明确。用CO和Er:YAG(铒:钇铝石榴石)进行机械激光治疗以及用白藓进行全身治疗也有效。不同的方法在特定情况下相对更有效,例如在免疫抑制患者、四肢的AK或较厚的AK中。结论:几项研究表明基于联合治疗的方法提高了PDT的有效性。然而,需要更多的研究来进一步了解联合治疗在临床实践中的有效性,并研究阿维A、甲氨蝶呤、维生素D、热机械微损伤和微晶磨皮在人体中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a16a/9416092/1f2da0993d51/pharmaceutics-14-01726-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a16a/9416092/2a8500a2cbab/pharmaceutics-14-01726-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a16a/9416092/1f2da0993d51/pharmaceutics-14-01726-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a16a/9416092/2a8500a2cbab/pharmaceutics-14-01726-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a16a/9416092/1f2da0993d51/pharmaceutics-14-01726-g002.jpg

相似文献

1
Combination-Based Strategies for the Treatment of Actinic Keratoses with Photodynamic Therapy: An Evidence-Based Review.光动力疗法治疗光化性角化病的联合治疗策略:循证综述
Pharmaceutics. 2022 Aug 18;14(8):1726. doi: 10.3390/pharmaceutics14081726.
2
Topical tacalcitol as neoadjuvant for photodynamic therapy of acral actinic keratoses: An intra-patient randomized study.外用他卡西醇作为足背光化性角化病光动力治疗的新辅助治疗:一项患者内随机研究。
Photodiagnosis Photodyn Ther. 2020 Sep;31:101803. doi: 10.1016/j.pdpdt.2020.101803. Epub 2020 May 8.
3
Sequential treatment with calcitriol and methyl aminolevulinate-daylight photodynamic therapy for patients with multiple actinic keratoses of the upper extremities.序贯用骨化三醇和氨甲环酸光动力疗法治疗上肢多发性光化性角化病。
Photodiagnosis Photodyn Ther. 2021 Jun;34:102325. doi: 10.1016/j.pdpdt.2021.102325. Epub 2021 May 15.
4
Fractional Ablative Laser-Assisted Photodynamic Therapy as Field Treatment for Actinic Keratoses: Our Anecdotal Experience.激光辅助光动力学疗法治疗光化性角化病:我们的经验。
Skinmed. 2020 Aug 1;18(4):214-216. eCollection 2020.
5
Polypodium leucotomos supplementation in the treatment of scalp actinic keratosis: could it improve the efficacy of photodynamic therapy?白叶铁线蕨补充剂治疗头皮光化性角化病:它能提高光动力疗法的疗效吗?
Dermatol Surg. 2015 Aug;41(8):898-902. doi: 10.1097/DSS.0000000000000425.
6
A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.一项比较卡泊三醇辅助氨甲环酸光动力疗法(MAL-PDT)与常规 MAL-PDT 治疗光化性角化病的随机头皮分裂研究。
Br J Dermatol. 2018 Oct;179(4):829-835. doi: 10.1111/bjd.16473. Epub 2018 May 15.
7
Intensified fractional CO2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: a randomized half-side comparative trial on dorsal hands.强化分数 CO2 激光辅助光动力疗法与单独激光治疗多发性光化性角化病和疣状病变的器官移植受者:背部手部的随机半侧对照试验。
Br J Dermatol. 2013 Nov;169(5):1087-92. doi: 10.1111/bjd.12507.
8
Treatment Satisfaction and Acceptability of 20% Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses of the Face, Scalp, and Upper Extremities.20%氨基乙酰丙酸光动力疗法治疗面部、头皮和上肢光化性角化病的治疗满意度和可接受性
J Clin Aesthet Dermatol. 2023 Dec;16(12):46-51.
9
Photodynamic therapy for actinic keratoses: survey of patient perceptions of treatment satisfaction and outcomes.光动力疗法治疗光化性角化病:患者对治疗满意度及疗效的认知调查
J Cosmet Laser Ther. 2008 Jun;10(2):81-6. doi: 10.1080/14764170802056117.
10
Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.使用氨基乙酰丙酸对面部和头皮非角化过度性光化性角化病患者进行光动力疗法:一项为期12个月随访的IV期多中心临床试验。
Br J Dermatol. 2006 Dec;155(6):1262-9. doi: 10.1111/j.1365-2133.2006.07520.x.

引用本文的文献

1
Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation.抗脱发和生发药妆品的技术进步:多学科协同创新驱动的机制突破与产业前景
Aesthetic Plast Surg. 2025 Aug 11. doi: 10.1007/s00266-025-05077-3.
2
Clinical Applications of (Fernblock): An Update.(费恩布洛克)的临床应用:最新进展
Life (Basel). 2023 Jul 5;13(7):1513. doi: 10.3390/life13071513.
3
Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events.

本文引用的文献

1
Advances and future perspectives in epithelial drug delivery.上皮给药的进展与未来展望。
Adv Drug Deliv Rev. 2022 Jul;186:114293. doi: 10.1016/j.addr.2022.114293. Epub 2022 Apr 26.
2
Photodynamic Therapy for Actinic Keratoses of the Upper Extremities using 10% Aminolevulinic Acid Gel, Red Light, and Adapalene Pretreatment.使用10%氨基乙酰丙酸凝胶、红光和阿达帕林预处理对上肢光化性角化病进行光动力治疗
J Clin Aesthet Dermatol. 2021 Oct;14(10):19-24.
3
A 12-month follow-up split-scalp study comparing calcipotriol-assisted MAL-PDT with conventional MAL-PDT for the treatment of actinic keratosis: a randomized controlled trial.
激光辅助药物递送:安全性与不良事件的系统评价
Pharmaceutics. 2022 Dec 7;14(12):2738. doi: 10.3390/pharmaceutics14122738.
4
Editorial on the "Special Issue in Honor of Dr. Michael Weber's 70th Birthday: Photodynamic Therapy: Rising Star in Pharmaceutical Applications".关于“纪念迈克尔·韦伯博士70岁生日特刊:光动力疗法:药物应用中的后起之秀”的社论
Pharmaceutics. 2022 Aug 26;14(9):1786. doi: 10.3390/pharmaceutics14091786.
一项为期 12 个月的对照头皮研究,比较钙泊三醇辅助 MAL-PDT 与传统 MAL-PDT 治疗光化性角化病:一项随机对照试验。
Eur J Dermatol. 2021 Oct 1;31(5):638-644. doi: 10.1684/ejd.2021.4137.
4
Stimulation and homogenization of the protoporphyrin IX endogenous production by photobiomodulation to increase the potency of photodynamic therapy.通过光生物调节刺激和匀化原卟啉 IX 的内源性产生,以提高光动力疗法的疗效。
J Photochem Photobiol B. 2021 Dec;225:112347. doi: 10.1016/j.jphotobiol.2021.112347. Epub 2021 Oct 28.
5
Micro- and Nano-Based Transdermal Delivery Systems of Photosensitizing Drugs for the Treatment of Cutaneous Malignancies.用于治疗皮肤恶性肿瘤的光敏药物的基于微米和纳米的透皮给药系统
Pharmaceuticals (Basel). 2021 Aug 6;14(8):772. doi: 10.3390/ph14080772.
6
Topical drug delivery: History, percutaneous absorption, and product development.局部药物递送:历史、经皮吸收和产品开发。
Adv Drug Deliv Rev. 2021 Oct;177:113929. doi: 10.1016/j.addr.2021.113929. Epub 2021 Aug 14.
7
Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis: A Systematic Review and Network Meta-analysis.评价光化性角化病干预措施的长期清除率:系统评价和网络荟萃分析。
JAMA Dermatol. 2021 Sep 1;157(9):1066-1077. doi: 10.1001/jamadermatol.2021.2779.
8
Sequential treatment with calcitriol and methyl aminolevulinate-daylight photodynamic therapy for patients with multiple actinic keratoses of the upper extremities.序贯用骨化三醇和氨甲环酸光动力疗法治疗上肢多发性光化性角化病。
Photodiagnosis Photodyn Ther. 2021 Jun;34:102325. doi: 10.1016/j.pdpdt.2021.102325. Epub 2021 May 15.
9
Guidelines of care for the management of actinic keratosis.光化性角化病治疗管理指南。
J Am Acad Dermatol. 2021 Oct;85(4):e209-e233. doi: 10.1016/j.jaad.2021.02.082. Epub 2021 Apr 2.
10
MAL-associated methyl nicotinate for topical PDT improvement.用于局部光动力疗法改善的 MAL 相关烟碱酸甲酯。
J Photochem Photobiol B. 2020 Dec;213:112071. doi: 10.1016/j.jphotobiol.2020.112071. Epub 2020 Nov 2.